蛋白质组
神经科学
蛋白质组学
背景(考古学)
疾病
生物
小胶质细胞
阿尔茨海默病
神经退行性变
神经炎症
生物信息学
医学
免疫学
病理
遗传学
炎症
古生物学
基因
作者
Jong‐Heon Kim,Ruqayya Afridi,Won‐Ha Lee,Kyoungho Suk
标识
DOI:10.1080/14789450.2023.2260955
摘要
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline, memory loss, and changes in behavior. Accumulating evidence indicates that dysfunction of glial cells, including astrocytes, microglia, and oligodendrocytes, may contribute to the development and progression of AD. Large-scale analysis of glial proteins sheds light on their roles in cellular processes and diseases. In AD, glial proteomics has been utilized to understand glia-based pathophysiology and identify potential biomarkers and therapeutic targets.In this review, we provide an updated overview of proteomic analysis of glia in the context of AD. Additionally, we discuss current challenges in the field, involving glial complexity and heterogeneity, and describe some cutting-edge proteomic technologies to address them.Unbiased comprehensive analysis of glial proteomes aids our understanding of the molecular and cellular mechanisms of AD pathogenesis. These investigations highlight the crucial role of glial cells and provide novel insights into the mechanisms of AD pathology. A deeper understanding of the AD-related glial proteome could offer a repertoire of potential biomarkers and therapeutics. Further technical advancement of glial proteomics will enable us to identify proteins within individual cells and specific cell types, thus significantly enhancing our comprehension of AD pathogenesis.
科研通智能强力驱动
Strongly Powered by AbleSci AI